ARTICLE | Clinical News
Perindopril/amlodipine: Phase III started
May 14, 2012 7:00 AM UTC
In late February, Xoma began the double-blind, U.S. Phase III PATH trial to compare an oral fixed-dose combination of perindopril plus amlodipine once daily for 6 weeks vs. perindopril or amlodipine a...